To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study
| dc.rights.license | open | en_US |
| dc.contributor.author | COMPAORE, Zoewendtale Cyrille | |
| dc.contributor.author | MONNET, Elisabeth | |
| dc.contributor.author | GERAZIME, Aurelie | |
| dc.contributor.author | MOLINIE, Florence | |
| dc.contributor.author | GUIZARD, Anne-Valerie | |
| dc.contributor.author | DELAFOSSE, Patricia | |
| dc.contributor.author | DABAKUYO-YONLI, Tienhan Sandrine | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | COUREAU, Gaelle | |
| dc.contributor.author | HAMMAS, Karima | |
| dc.contributor.author | PLOUVIER, Sandrine | |
| dc.contributor.author | BARA, Simona | |
| dc.contributor.author | DEFOSSEZ, Gautier | |
| dc.contributor.author | LAPOTRE-LEDOUX, Benedicte | |
| dc.contributor.author | DAUBISSE-MARLIAC, Laetitia | |
| dc.contributor.author | D'ALMEIDA, Tania | |
| dc.contributor.author | LAUNOY, Guy | |
| dc.contributor.author | MANSI, Laura | |
| dc.contributor.author | TRETARRE, Brigitte | |
| dc.contributor.author | WORONOFF, Anne-Sophie | |
| dc.date.accessioned | 2022-03-04T13:44:20Z | |
| dc.date.available | 2022-03-04T13:44:20Z | |
| dc.date.issued | 2022-01-26 | |
| dc.identifier.issn | 1573-7225 (Electronic) 0957-5243 (Linking) | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/128828 | |
| dc.description.abstractEn | PURPOSE: In an attempt to understand why cervical cancer (CC) survival is decreasing with diagnosis period among older women in France, this study aimed to estimate the effects of main prognostic factors on net survival in CC according to age. METHODS: French cancer registries databases were used to retrospectively analyze women diagnosed with CC in 2011-2012. Net survival was estimated with the Pohar-Perme method and prognostic factors (socio-demographic, clinical variables, stage at diagnosis, therapeutic management) were analyzed with Lambert and Royston's flexible parametric model. RESULTS: One thousand one hundred fifty three women with CC were identified. 30.4% were < 45, 41.4% 45-64, and 28.3% ≥ 65 years. Older women were diagnosed at a more advanced stage than younger women: 54.8% regional (FIGO IB2-IVA), 33.0% distant (IVB) in women ≥ 65 years vs 33.7% and 8.0%, respectively in women < 45 years. Half of women with regional stage of CC received recommended treatment; this rate decreased with increasing age (< 45: 66.1%, 45-64: 62.7%, ≥ 65: 29.2%). Older age was significantly associated with increased risk of death: hazard ratio 1.89 for age ≥ 65, as were regional stage (2.81), distant stage (15.99), and not receiving recommended treatment (2.26). CONCLUSION: Older women with CC diagnosed at advanced stage who do not receive standard of care are at markedly increased risk of death. Special attention to the management of older women is warranted in France, not only to diagnose cancer at an earlier stage (via gynecological follow-up in these menopaused women who remain at risk of CC), but also to ensure they receive standard of care, taking into account their overall state of health. | |
| dc.language.iso | EN | en_US |
| dc.subject.en | Cervical cancer | |
| dc.subject.en | Net survival | |
| dc.subject.en | Prognostic factors | |
| dc.subject.en | Older women | |
| dc.subject.en | Stage | |
| dc.subject.en | Treatment | |
| dc.title.en | To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study | |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1007/s10552-021-01536-9 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
| dc.identifier.pubmed | 35079925 | en_US |
| bordeaux.journal | Cancer Causes and Control | en_US |
| bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.team | EPICENE_BPH | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.identifier.funderID | Institut National Du Cancer | en_US |
| hal.identifier | hal-03597864 | |
| hal.version | 1 | |
| hal.date.transferred | 2022-03-04T13:44:23Z | |
| hal.export | true | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Cancer%20Causes%20and%20Control&rft.date=2022-01-26&rft.eissn=1573-7225%20(Electronic)%200957-5243%20(Linking)&rft.issn=1573-7225%20(Electronic)%200957-5243%20(Linking)&rft.au=COMPAORE,%20Zoewendtale%20Cyrille&MONNET,%20Elisabeth&GERAZIME,%20Aurelie&MOLINIE,%20Florence&GUIZARD,%20Anne-Valerie&rft.genre=article |
Fichier(s) constituant ce document
| Fichiers | Taille | Format | Vue |
|---|---|---|---|
|
Il n'y a pas de fichiers associés à ce document. |
|||